GeneLink, Inc. (GNLKQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
May 1, 2025, 4:00 PM EDT
GeneLink Revenue
GeneLink had revenue of $294.74K in the quarter ending September 30, 2013, a decrease of -30.66%. This brings the company's revenue in the last twelve months to $1.58M, down -39.39% year-over-year. In the year 2012, GeneLink had annual revenue of $2.14M, down -54.40%.
Revenue (ttm)
1.58M
Revenue Growth
-39.39%
P/S Ratio
0.01
Revenue / Employee
112.79K
Employees
14
Market Cap
10.60K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2012 | 2.14M | -2.55M | -54.40% |
| Dec 31, 2011 | 4.68M | -3.16M | -40.25% |
| Dec 31, 2010 | 7.84M | -721.48K | -8.43% |
| Dec 31, 2009 | 8.56M | 2.18M | 34.25% |
| Dec 31, 2008 | 6.38M | 6.28M | 6,424.64% |
| Dec 31, 2007 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
| Dec 31, 2005 | Pro | Pro | Pro |
| Dec 31, 2004 | Pro | Pro | Pro |
| Dec 31, 2003 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |